Clopidogrel Bisulfate NDC 47335-894

NDC codes

FDA NDC Directory

Product NDC (as listed)47335-894Labeler and product segments. Claims need a package NDC.

Product NDC at billing width47335-0894Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
47335-894-13	47335089413	500 TABLET, FILM COATED in 1 BOTTLE (47335-894-13)Marketed from May 18, 2012
47335-894-18	47335089418	1000 TABLET, FILM COATED in 1 BOTTLE (47335-894-18)Marketed from May 18, 2012
47335-894-19	47335089419	90 TABLET, FILM COATED in 1 BOTTLE (47335-894-19)Marketed from May 18, 2012
47335-894-81	47335089481	90 TABLET, FILM COATED in 1 BOTTLE (47335-894-81)Marketed from May 18, 2012
47335-894-83	47335089483	30 TABLET, FILM COATED in 1 BOTTLE (47335-894-83)Marketed from May 18, 2012

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clopidogrel Bisulfate
Generic name (nonproprietary): clopidogrel bisulfate
Active ingredients: Clopidogrel bisulfate — 75 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Sun Pharmaceutical Industries, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090494
Marketing start: May 18, 2012
Listing expires: Dec 31, 2026
Other FDA classes: Cytochrome P450 2C8 Inhibitors (Mechanism)Decreased Platelet Aggregation (Physiologic effect)P2Y12 Receptor Antagonists (Mechanism)
Identifiers: Product ID 47335-894_2de2d0fb-68e7-4a22-8da8-be7658468f15SPL ID 2de2d0fb-68e7-4a22-8da8-be7658468f15SPL set ID d37db064-3a5a-4a0c-a60b-b4b417fe742aRxCUI 309362UNII 08I79HTP27UPC 0347335894813
Pharmacologic class: P2Y12 Platelet Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N447335089413 followed by a unit qualifier and the quantity

Package 47335-0894-13. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 23, 2022. This label includes a boxed warning.

Indications (excerpt from the label)

Clopidogrel is a P2Y 12 platelet inhibitor indicated for: Acute coronary syndrome - For patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)], clopidogrel tablets have been shown to reduce the rate of myocardial infarction (MI) and stroke. ( 1.1 ) - For patients with ST-elevation myocardial infarction (STEMI), clopidogrel tablets have been shown to reduce the rate of MI and stroke. ( 1.1 ) Recent MI, recent stroke, or established peripheral arterial disease. Clopidogrel tablets have been shown to reduce the rate of MI and stroke. ( 1.2 ) 1.1 Acute Coronary Syndrome (ACS) Clopidogrel tablets are indicated to reduce the rate of myocar…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)